Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ InactivationYusuke Oku(Iwate Medical University), Yoshimasa Uehara(Iwate Medical University)Anticancer ResearchMay 30, 201810.21873/anticanres.12617Cited by 11SaveCiteExport RISWatch citationsRelated PapersBimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors|Molecular Cancer Therapeutics|2004|46